125 related articles for article (PubMed ID: 23496868)
1. Representativeness of an HIV cohort of the sites from which it is recruiting: results from the Ontario HIV Treatment Network (OHTN) cohort study.
Raboud J; Su D; Burchell AN; Gardner S; Walmsley S; Bayoumi AM; Blitz S; Cooper C; Salit I; Cohen J; Rourke SB; Loutfy MR
BMC Med Res Methodol; 2013 Mar; 13():31. PubMed ID: 23496868
[TBL] [Abstract][Full Text] [Related]
2. High retention in HIV care at a tertiary care centre in Toronto, Canada.
Szadkowski L; Walmsley S; Burchell AN; Collins E; Rourke SB; Raboud J;
AIDS Care; 2018 Feb; 30(2):246-254. PubMed ID: 28678619
[TBL] [Abstract][Full Text] [Related]
3. Social determinants of health and retention in HIV care in a clinical cohort in Ontario, Canada.
Rachlis B; Burchell AN; Gardner S; Light L; Raboud J; Antoniou T; Bacon J; Benoit A; Cooper C; Kendall C; Loutfy M; Wobeser W; McGee F; Rachlis A; Rourke SB;
AIDS Care; 2017 Jul; 29(7):828-837. PubMed ID: 28027668
[TBL] [Abstract][Full Text] [Related]
4. U.S. trends in antiretroviral therapy use, HIV RNA plasma viral loads, and CD4 T-lymphocyte cell counts among HIV-infected persons, 2000 to 2008.
Althoff KN; Buchacz K; Hall HI; Zhang J; Hanna DB; Rebeiro P; Gange SJ; Moore RD; Kitahata MM; Gebo KA; Martin J; Justice AC; Horberg MA; Hogg RS; Sterling TR; Cescon A; Klein MB; Thorne JE; Crane HM; Mugavero MJ; Napravnik S; Kirk GD; Jacobson LP; Brooks JT;
Ann Intern Med; 2012 Sep; 157(5):325-35. PubMed ID: 22944874
[TBL] [Abstract][Full Text] [Related]
5. Regional differences in rates of HIV-1 viral load monitoring in Canada: Insights and implications for antiretroviral care in high income countries.
Raboud JM; Loutfy MR; Su D; Bayoumi AM; Klein MB; Cooper C; Machouf N; Rourke S; Walmsley S; Rachlis A; Harrigan PR; Smieja M; Tsoukas C; Montaner JS; Hogg RS;
BMC Infect Dis; 2010 Feb; 10():40. PubMed ID: 20184766
[TBL] [Abstract][Full Text] [Related]
6. Association of Multiple Primary Skin Cancers With Human Immunodeficiency Virus Infection, CD4 Count, and Viral Load.
Asgari MM; Ray GT; Quesenberry CP; Katz KA; Silverberg MJ
JAMA Dermatol; 2017 Sep; 153(9):892-896. PubMed ID: 28700773
[TBL] [Abstract][Full Text] [Related]
7. Impact of hepatitis B and C co-infection on health-related quality of life in HIV positive individuals.
Gillis J; Cooper C; Rourke S; Rueda S; O'Brien K; Collins E; Rachlis A; Hart TA; Raboud J;
Qual Life Res; 2013 Sep; 22(7):1525-35. PubMed ID: 23070749
[TBL] [Abstract][Full Text] [Related]
8. Late diagnosis, delayed presentation and late presentation among persons enrolled in a clinical HIV cohort in Ontario, Canada (1999-2013).
Wilton J; Light L; Gardner S; Rachlis B; Conway T; Cooper C; Cupido P; Kendall CE; Loutfy M; McGee F; Murray J; Lush J; Rachlis A; Wobeser W; Bacon J; Kroch AE; Gilbert M; Rourke SB; Burchell AN;
HIV Med; 2019 Feb; 20(2):110-120. PubMed ID: 30430742
[TBL] [Abstract][Full Text] [Related]
9. Implementation and Operational Research: Engagement in HIV Care Among Persons Enrolled in a Clinical HIV Cohort in Ontario, Canada, 2001-2011.
Burchell AN; Gardner S; Light L; Ellis BM; Antoniou T; Bacon J; Benoit A; Cooper C; Kendall C; Loutfy M; McGee F; Raboud J; Rachlis A; Wobeser W; Rourke SB
J Acquir Immune Defic Syndr; 2015 Sep; 70(1):e10-9. PubMed ID: 26322672
[TBL] [Abstract][Full Text] [Related]
10. Cohort profile: the Ontario HIV Treatment Network Cohort Study (OCS).
Rourke SB; Gardner S; Burchell AN; Raboud J; Rueda S; Bayoumi AM; Loutfy M; Cooper C; Smieja M; Taylor D; DiPede T; Wobeser W; Major C; Waring V; Fisher M; Cairney J; Mittmann N; Salit IE; Crouzat F; Gough K; Ralph E; Sandre R; Kilby D; Rachlis A
Int J Epidemiol; 2013 Apr; 42(2):402-11. PubMed ID: 22345312
[TBL] [Abstract][Full Text] [Related]
11. Cohort profile: Development and profile of a population-based, retrospective cohort of diagnosed people living with HIV in Ontario, Canada (Ontario HIV Laboratory Cohort).
Liu J; Wilton J; Sullivan A; Marchand-Austin A; Rachlis B; Giles M; Light L; Sider D; Kroch AE; Gilbert M;
BMJ Open; 2019 May; 9(5):e027325. PubMed ID: 31133591
[TBL] [Abstract][Full Text] [Related]
12. Effect of valaciclovir on CD4 count decline in untreated HIV: an international randomized controlled trial.
Tan DHS; Raboud JM; Szadkowski L; Grinsztejn B; Madruga JV; Figueroa MI; Cahn P; Barton SE; Clarke A; Fox J; Zubyk W; Walmsley SL;
J Antimicrob Chemother; 2019 Feb; 74(2):480-488. PubMed ID: 30376108
[TBL] [Abstract][Full Text] [Related]
13. The impact of drug coverage on viral suppression among people living with HIV in Ontario, Canada.
Rachlis B; Light L; Gardner S; Burchell AN; Raboud J; Kendall C; McIsaac MA; Murray J; Rachlis A; Rourke SB
Can J Public Health; 2018 Dec; 109(5-6):800-809. PubMed ID: 30140981
[TBL] [Abstract][Full Text] [Related]
14. Factors associated with virological suppression among HIV-positive individuals on highly active antiretroviral therapy in a multi-site Canadian cohort.
Cescon AM; Cooper C; Chan K; Palmer AK; Klein MB; Machouf N; Loutfy MR; Raboud J; Rachlis A; Ding E; Lima VD; Montaner JS; Rourke SB; Smieja M; Tsoukas C; Hogg RS;
HIV Med; 2011 Jul; 12(6):352-60. PubMed ID: 21059167
[TBL] [Abstract][Full Text] [Related]
15. Association of CD4+ T-cell Count, HIV-1 RNA Viral Load, and Antiretroviral Therapy With Kaposi Sarcoma Risk Among HIV-infected Persons in the United States and Canada.
Dubrow R; Qin L; Lin H; Hernández-Ramírez RU; Neugebauer RS; Leyden W; Althoff KN; Achenbach CJ; Hessol NA; Modur SP; DʼSouza G; Bosch RJ; Grover S; Horberg MA; Kitahata MM; Mayor AM; Novak RM; Rabkin CS; Sterling TR; Goedert JJ; Justice AC; Engels EA; Moore RD; Silverberg MJ;
J Acquir Immune Defic Syndr; 2017 Aug; 75(4):382-390. PubMed ID: 28394855
[TBL] [Abstract][Full Text] [Related]
16. Differences in Virological and Immunological Risk Factors for Non-Hodgkin and Hodgkin Lymphoma.
Shepherd L; Ryom L; Law M; Hatleberg CI; de Wit S; Monforte AD; Battegay M; Phillips A; Bonnet F; Reiss P; Pradier C; Grulich A; Sabin C; Lundgren J; Mocroft A
J Natl Cancer Inst; 2018 Jun; 110(6):598-607. PubMed ID: 29267895
[TBL] [Abstract][Full Text] [Related]
17. Plasma HIV-2 RNA According to CD4 Count Strata among HIV-2-Infected Adults in the IeDEA West Africa Collaboration.
Ekouévi DK; Avettand-Fènoël V; Tchounga BK; Coffie PA; Sawadogo A; Minta D; Minga A; Eholie SP; Plantier JC; Damond F; Dabis F; Rouzioux C;
PLoS One; 2015; 10(6):e0129886. PubMed ID: 26111242
[TBL] [Abstract][Full Text] [Related]
18. Disparities in achieving and sustaining viral suppression among a large cohort of HIV-infected persons in care - Washington, DC.
Castel AD; Kalmin MM; Hart RL; Young HA; Hays H; Benator D; Kumar P; Elion R; Parenti D; Ruiz ME; Wood A; D'Angelo L; Rakhmanina N; Rana S; Bryant M; Hebou A; Fernández R; Abbott S; Peterson J; Wood K; Subramanian T; Binkley J; Happ LP; Kharfen M; Masur H; Greenberg AE
AIDS Care; 2016 Nov; 28(11):1355-64. PubMed ID: 27297952
[TBL] [Abstract][Full Text] [Related]
19. Prognostic factors of combined viral load and CD4+ cell count responses under triple antiretroviral therapy, Aquitaine cohort, 1996-1998.
Marimoutou C; Chêne G; Mercié P; Neau D; Farbos S; Morlat P; Ceccaldi J; Dabis F;
J Acquir Immune Defic Syndr; 2001 Jun; 27(2):161-7. PubMed ID: 11404538
[TBL] [Abstract][Full Text] [Related]
20. Life expectancy of HIV-positive individuals on combination antiretroviral therapy in Canada.
Patterson S; Cescon A; Samji H; Chan K; Zhang W; Raboud J; Burchell AN; Cooper C; Klein MB; Rourke SB; Loutfy MR; Machouf N; Montaner JS; Tsoukas C; Hogg RS;
BMC Infect Dis; 2015 Jul; 15():274. PubMed ID: 26183704
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
